TORONTO, Feb. 19 /CNW/ - Patheon Inc. (TSX: PTI) today announced changes
in the roles of several of the Company's senior executives.
"This re-alignment of responsibilities will result in a more focused and
effective executive team, enabling us to move forward to build and grow our
business," said Mr. Wesley P. Wheeler, Chief Executive Officer, Patheon Inc.
Nick DiPietro will be assuming a new role as Executive Vice-President,
Corporate Development and, accordingly, will relinquish his responsibilities
as President and Chief Operating Officer of Patheon, effective March 1, 2008.
In his new role, Mr. DiPietro will lead the development of a long-term
corporate strategy and assist in evaluating future growth opportunities. He
will continue to report to Wes Wheeler, Chief Executive Officer of Patheon
"I look forward to Nick's leadership and capitalizing on his creativity
and entrepreneurial talent as we develop a new strategic plan for Patheon,"
said Mr. Wheeler.
Clive Bennett, currently President, Patheon U.S.A., will assume a new
role as Chief Technical Officer, reporting to Wes Wheeler, CEO, effective
March 1, 2008. In this newly created role, Mr. Bennett will be responsible for
Patheon's global quality, supply chain, information technology and engineering
functions. He also will continue to lead the Company in the divestiture of its
Carolina Operations facility in Puerto Rico.
"With his extensive global experience, Clive is uniquely qualified for
this role," said Mr. Wheeler. "I look forward to working with him to further
harmonize Patheon's global operations and establish Patheon as the industry's
best provider of pharmaceutical development and commercial manufacturing
Steve Liberty is appointed Senior Vice-President, Operations, Canada and
U.S.A., and will assume responsibility for Patheon's Cincinnati and Burlington
Century Laboratory facilities in addition to his current leadership of the
Toronto Region, Whitby and York Mills sites. Mr. Liberty will report to
Terence Novak, who joined Patheon on February 18, 2008 as President, North
American Operations and Chief Marketing Officer.
Caution Concerning Forward-Looking Statements
This news release contains forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at www.patheon.com
Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 12 facilities in the United States,
Canada and Europe, employing more than 4,650 people and serving a client base
of more than 250 pharmaceutical and biotechnology companies.
For further information:
For further information: Mr. Wesley P. Wheeler, Chief Executive Officer,
Tel: (905) 812-2112, Fax: (905) 812-6613, Email: firstname.lastname@example.org;
Ms. Shelley Jourard, Director, Corporate Communications, Tel: (905) 812-6614,
Fax: (905) 812-6613, Email: email@example.com